Search results for

Omaha, Neb., is home to a toss-up Congressional race this year. Voters have shown a willingness to vote for moderate candidates from both parties, but has the definition of a moderate now changed?

Districts are supposed to tell the government how often students are held or detained. But a new report says those numbers are so inaccurate, there's no way of knowing the prevalence of these methods.

NPR's Steve Inskeep talks to Christopher Krebs, who was up until recently the top cybersecurity official in the country, about a computer hack of federal agencies. It's believed Russia is responsible.

President Trump and Congress Friday authorized a package of emergency funding to help and treat and slow the spread of COVID-19. About $950 million is designated for state and local response.

Global efforts to limit climate change can't happen without more aid. Rich countries promised $100 billion to poorer ones to cope with global warming but seven years later, have yet to deliver.

The "God Bless The USA" Bible is inspired by the Lee Greenwood anthem and includes copies of the nation's founding documents. Trump launched it ahead of Easter as his financial woes mount.

Updated 6:02, 6/6/19 Four Northeast Ohio nursing homes are on a list of troubled facilities that has been released to the public by two U.S. Senators. Canton Christian Home, Eliza Bryant Village in Cleveland, Hudson Elms Nursing Home and Stow Glen Health Care Center, were all found to have serious health, safety or sanitary problems according to the federal government.

Many consumers are confused by a growing list of appeals for tips, from vehicle repairs to takeout food.

It's easy to assume that once a military service member has left the ranks and returned home, they are out of harm’s way. However, readjustment to civilian life can be complicated. We discuss how the legal system can hamstring our most vulnerable veterans and how others have stepped in to help.

The number of prescriptions for ivermectin, a drug typically used to treat parasitic worms that have repeatedly failed in clinical trials to treat COVID-19 has soared. We look at what’s driving the demand for the drug and the associated risks.